Monograph Details
|
|
Eye Disorders
> Ocular allergy/inflammation
|
|
NAPHCON A |
| Manufacturer |
|
Alcon Laboratories, Inc. |
| Legal Classification |
|
OTC |
| Pharmacological Class |
|
Vasoconstrictor + antihistamine. |
| Generic Name |
|
Naphazoline HCl 0.025%, pheniramine maleate 0.3%; oph. soln; contains benzalkonium chloride. |
| Indications |
|
Ocular redness and itching. |
| Adults and Children |
|
<6yrs: not recommended. ≥6yrs: 1–2 drops up to 4 times daily. |
| Precautions |
|
Avoid prolonged use. Narrow-angle glaucoma. Hypertension. Cardiovascular disease. Urinary hesitancy. Reevaluate if eye pain, irritation, or visual changes worsen or persist beyond 72hrs. Pregnancy. Nursing mothers. |
| Interactions |
|
Avoid MAOIs. Remove soft contact lenses when instilling; may re-insert afterwards. |
| Adverse Reactions |
|
Mydriasis, increased IOP, local irritation, sensitization. |
| How Supplied |
|
Soln—15mL |
|
|
|
|
